Methods to overcome ocular barriers MCQs With Answer

Methods to Overcome Ocular Barriers MCQs With Answer is designed for M. Pharm students studying Drug Delivery Systems (MPH 102T). The eye has multiple protective barriers—tear turnover, blinking, corneal epithelium tight junctions, conjunctival clearance, and the blood–ocular barriers—that limit drug bioavailability, especially from topical drops. This quiz focuses on advanced pharmaceutical strategies that improve ocular drug delivery: mucoadhesive and in situ gelling systems, penetration enhancers, cyclodextrins, prodrugs, nanocarriers, ocular inserts, contact-lens based delivery, iontophoresis, and targeted periocular or intravitreal routes. You will find clinically relevant examples such as dipivefrin, Ozurdex, and gellan-based gels, along with mechanistic questions on overcoming efflux, enhancing corneal permeation, and reaching the posterior segment. Use this set to test and deepen your understanding.

Q1. Which ocular barrier most restricts the passage of hydrophilic drugs following topical administration?

• Corneal epithelium with tight junctions
• Corneal stroma (collagenous layer)
• Conjunctival lymphatics
• Vitreous humor viscosity

Correct Answer: Corneal epithelium with tight junctions

Q2. For lipophilic molecules, which corneal layer primarily limits penetration due to its hydrophilic nature?

• Corneal stroma (hydrophilic barrier)
• Corneal epithelium
• Corneal endothelium
• Tear film lipid layer

Correct Answer: Corneal stroma (hydrophilic barrier)

Q3. The major cause of low ocular bioavailability from conventional eye drops is:

• Precorneal loss due to tear turnover and nasolacrimal drainage
• Low intrinsic drug potency
• Excessively high corneal permeability
• Rapid penetration through the blood–retinal barrier

Correct Answer: Precorneal loss due to tear turnover and nasolacrimal drainage

Q4. Which strategy is most effective at prolonging precorneal residence time of a topically applied drug?

• Mucoadhesive in situ gel
• Reducing drug concentration
• Increasing dropper orifice diameter
• Using sterile water alone

Correct Answer: Mucoadhesive in situ gel

Q5. Identify an ion-activated in situ gelling polymer commonly used in ocular formulations:

• Gellan gum (Gelrite)
• Poloxamer 407
• Eudragit RL
• PEG 400

Correct Answer: Gellan gum (Gelrite)

Q6. Which temperature-responsive polymer forms a gel on the ocular surface at physiological temperatures?

• Poloxamer 407
• Carbopol 974P
• Chitosan HCl
• Hydroxypropyl-β-cyclodextrin

Correct Answer: Poloxamer 407

Q7. Which delivery approach most effectively bypasses the blood–retinal barrier for posterior segment therapy?

• Intravitreal implant
• Topical eye drops
• Sublingual tablets
• Retrobulbar anesthesia

Correct Answer: Intravitreal implant

Q8. Which is a classic prodrug used to enhance corneal penetration of epinephrine?

• Dipivefrin
• Timolol maleate
• Dorzolamide
• Brinzolamide

Correct Answer: Dipivefrin

Q9. What is the principal role of cyclodextrins in ocular drug delivery?

• Form inclusion complexes to increase solubility and corneal flux
• Disrupt the blood–retinal barrier
• Increase tear turnover rate
• Replace ocular mucins

Correct Answer: Form inclusion complexes to increase solubility and corneal flux

Q10. For a highly lipophilic antiglaucoma drug, which carrier is most suitable to improve corneal penetration and stability?

• Nanostructured lipid carriers
• Aqueous saline solution
• Large microcrystals
• Gas-filled microbubbles

Correct Answer: Nanostructured lipid carriers

Q11. Which approach most effectively reduces systemic absorption after instillation of eye drops?

• Punctal occlusion or punctal plugs
• Use of hypertonic solutions
• Prolonged contact of dropper tip with the eye
• Increasing the instilled volume to 100 μL

Correct Answer: Punctal occlusion or punctal plugs

Q12. Which statement best describes chitosan’s value in ocular delivery?

• Cationic polymer that is mucoadhesive and can open tight junctions
• Anionic polymer that reduces viscosity
• Non-biodegradable silicone elastomer
• Highly irritant preservative for ophthalmic use

Correct Answer: Cationic polymer that is mucoadhesive and can open tight junctions

Q13. Ocular iontophoresis enhances drug delivery primarily by:

• Applying mild electric current to drive charged molecules through tissues
• Ultrasound-induced cavitation
• Magnetic targeting of nanoparticles
• Thermal ablation of epithelial barriers

Correct Answer: Applying mild electric current to drive charged molecules through tissues

Q14. Contact lens–based drug delivery systems primarily overcome which limitation of topical eye drops?

• Precorneal loss via tear turnover and blinking
• Blood–retinal barrier
• Corneal epithelial thickness
• Lens capsule barrier

Correct Answer: Precorneal loss via tear turnover and blinking

Q15. Which of the following is a biodegradable intravitreal implant providing sustained corticosteroid release?

• Ozurdex (dexamethasone)
• Retisert (fluocinolone acetonide)
• Iluvien (fluocinolone acetonide)
• Healon (sodium hyaluronate)

Correct Answer: Ozurdex (dexamethasone)

Q16. Suprachoroidal injection is designed to target which ocular tissues preferentially?

• Choroid and retina with limited anterior segment exposure
• Corneal epithelium only
• Vitreous base exclusively
• Lacrimal gland

Correct Answer: Choroid and retina with limited anterior segment exposure

Q17. Which excipient can transiently loosen corneal epithelial tight junctions by chelating calcium ions?

• Disodium EDTA
• Sodium chloride
• Mannitol
• Tween 80

Correct Answer: Disodium EDTA

Q18. By what mechanism can benzalkonium chloride (BAK) enhance corneal drug absorption, despite toxicity concerns?

• Surfactant-mediated membrane disruption increasing permeability
• Chelation of extracellular calcium
• Formation of liposomal vesicles
• Increasing tear viscosity and residence time

Correct Answer: Surfactant-mediated membrane disruption increasing permeability

Q19. Which ocular insert historically provided sustained pilocarpine delivery to overcome rapid precorneal clearance?

• Ocusert
• Vitrasert
• Dextenza
• Proclear

Correct Answer: Ocusert

Q20. Which approach can mitigate P-glycoprotein–mediated efflux in corneal epithelium without systemic inhibitors?

• Encapsulation in nanoparticles to facilitate endocytosis-mediated uptake
• Co-administering high-dose systemic cyclosporine A
• Increasing ophthalmic drop volume
• Using isotonic saline placebo

Correct Answer: Encapsulation in nanoparticles to facilitate endocytosis-mediated uptake

Download